N/A
Completed N=106
QL vs PENG for Analgesia After Hip Arthroplasty
Block · hip replacement · Postoperative Pain
Source: ClinicalTrials.gov NCT05710107 ↗
Enrolled (actual)
106
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcomePrimary: Postoperative Cumulative Opioid Consumption — 12.7; 9.9; 29.4; 23.2 morphine milligram equivalents
Summary
This study will consist of patients 18 years and older who are undergoing elective hip replacement with planned same day discharge. The patients will be randomized to receive a PENG+LFC or QL block prior to undergoing the surgery to help with postoperative pain control. The primary goal will be assessing postoperative opioid use during the first 72 hours after surgery. Secondary outcomes will include postoperative pain scores from, 0-72 hours. Additional outcomes consist of time to first ambulation, functional and mobility outcomes, PACU duration, patient satisfaction and opioid related side effects.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Postoperative Cumulative Opioid Consumption |
12.7; 9.9; 29.4; 23.2; 46.1; 36.4 | — |
| SECONDARY Average Postoperative Pain Score |
33.2; 29.5; 47.2; 43.5; 48.7; 45.1 | — |
Eligibility Criteria
Inclusion Criteria
- age greater than or equal to 18 years of age
- undergoing elective hip arthroplasty with planned same day discharge
Exclusion Criteria
- local anesthetic allergy
- subjects with a weight less than 40kg
- subjects that are unable or choose not to give informed consent
- Known preoperative substance abuse
Data sourced from ClinicalTrials.gov (NCT05710107). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.